Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Ho

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Current Oncology (Toronto, Ont.)|June 27, 2023
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack YearsAli Silver, Cheryl Ho, Qian Ye, et al.
Endocrine Pathology|November 23, 2024
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer ManagementOzgur Mete, Andrée Boucher, Kasmintan A Schrader, et al.
Investigational New Drugs|February 12, 2010
Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I studyCheryl Ho, Randeep Sangha, Laurel Beckett, et al.
Cold Spring Harbor Molecular Case Studies|December 25, 2019
Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic <i>DPYD</i> structural variantElisa Majounie, Kathleen Wee, Laura M Williamson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 26, 2025
Ultrarapid EGFR Testing in Non-Small Cell Lung Carcinoma Patients: Findings From a Canadian Clinical Testing WorkflowKate Fitzsimmons, Curtis Hughesman, Reka Pataky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2021
High-Ambient Air Pollution Exposure Among Never Smokers Versus Ever Smokers With Lung CancerRenelle Myers, Michael Brauer, Trevor Dummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung CancerBarbara Melosky, Helen Anderson, Ronald L Burkes, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2022
Defining a Core Data Set for the Economic Evaluation of Precision OncologySamantha Pollard, Deirdre Weymann, Brandon Chan, et al.
BMC Cancer|July 14, 2007
Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patientsTrevor J Pugh, Gwyn Bebb, Lorena Barclay, et al.
JCO Precision Oncology|August 8, 2024
"I Just Assumed This Was Already Being Done": Canadian Patient Preferences for Enhanced Data Sharing for Precision OncologySamantha Pollard, Morgan Ehman, Anna Hermansen, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Current Oncology (Toronto, Ont.)|June 27, 2023
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack YearsAli Silver, Cheryl Ho, Qian Ye, et al.
Endocrine Pathology|November 23, 2024
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer ManagementOzgur Mete, Andrée Boucher, Kasmintan A Schrader, et al.
Investigational New Drugs|February 12, 2010
Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I studyCheryl Ho, Randeep Sangha, Laurel Beckett, et al.
Cold Spring Harbor Molecular Case Studies|December 25, 2019
Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic <i>DPYD</i> structural variantElisa Majounie, Kathleen Wee, Laura M Williamson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 26, 2025
Ultrarapid EGFR Testing in Non-Small Cell Lung Carcinoma Patients: Findings From a Canadian Clinical Testing WorkflowKate Fitzsimmons, Curtis Hughesman, Reka Pataky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2021
High-Ambient Air Pollution Exposure Among Never Smokers Versus Ever Smokers With Lung CancerRenelle Myers, Michael Brauer, Trevor Dummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung CancerBarbara Melosky, Helen Anderson, Ronald L Burkes, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2022
Defining a Core Data Set for the Economic Evaluation of Precision OncologySamantha Pollard, Deirdre Weymann, Brandon Chan, et al.
BMC Cancer|July 14, 2007
Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patientsTrevor J Pugh, Gwyn Bebb, Lorena Barclay, et al.
JCO Precision Oncology|August 8, 2024
"I Just Assumed This Was Already Being Done": Canadian Patient Preferences for Enhanced Data Sharing for Precision OncologySamantha Pollard, Morgan Ehman, Anna Hermansen, et al.
Pageof 12